Clinical Trials Browser

Terminated × OTHER × Endometrial Neoplasms × Clear all

NCT05082025 2026-01-09

Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN Alterations

Phase 2 Terminated

7 enrolled 10 charts

Ovarian Neoplasms, Endometrial Neoplasms

NCT05263492 2025-10-02

Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer

Phase 2 Terminated

4 enrolled 8 charts

Recurrence, Endometrial Neoplasms

NCT05036681 2025-09-17

A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma

Phase 2 Terminated

9 enrolled 8 charts

Neoplasm Metastasis, Endometrial Neoplasms

NCT04159155 2025-08-12

CAN-STAMP

Phase 2/3 Terminated

Endometrial Neoplasms, Cystadenocarcinoma, Serous

NCT05714553 2025-07-18

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Phase 1/2 Terminated

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Esophageal Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT04527900 2025-06-19

The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach

Phase 2 Terminated

Endometrial Neoplasms

NCT03277482 2025-05-31

Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer

Phase 1 Terminated

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT05396794 2025-05-15

SCC-BAREDU

GynecologicOther

Obesity, Endometrial Neoplasms

NCT04514692 2025-04-23

Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging

Phase 1/2 Terminated

7 enrolled 9 charts

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT05523440 2025-03-28

Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation

Phase 2 Terminated

Ovarian Neoplasms, Endometrial Neoplasms

NCT04750941 2025-03-04

Study of Copanlisib and Ketogenic Diet

Phase 2 Terminated

1 enrolled 9 charts

GynecologicLymphoid

Lymphoma, Follicular, Endometrial Neoplasms

NCT04906382 2025-02-13

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Phase EARLY_PHASE1 Terminated

GastrointestinalGynecologic

Turcot syndrome, Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms

NCT03099499 2024-12-24

Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer

Phase 2 Terminated

Endometrial Neoplasms

NCT05877404 2024-04-19

Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer

Endometrial Neoplasms

NCT04743999 2024-03-29

Evaluation of Outcomes in Women Undergoing Multimodality Treatment for Advanced Stage Endometrial Carcinoma

Phase 2 Terminated

9 enrolled 8 charts

Endometrial Neoplasms

NCT04970368 2024-01-05

Comparison of Nodal Staging in Endometrial Cancer

Phase 3 Terminated

Neoplasms, Endometrial Neoplasms

NCT03694834 2023-11-28

Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

Phase EARLY_PHASE1 Terminated

Uterine Neoplasms, Endometrial Neoplasms

NCT05332483 2023-11-03

MA-EEC

Phase 1 Terminated

Endometrial Neoplasms

NCT03642990 2023-04-12

NR in Chemo-induced Peripheral Neuropathy

Phase 2 Terminated

5 enrolled 11 charts

GynecologicHead & Neck

Head and Neck Neoplasms, Endometrial Neoplasms

NCT03572478 2021-03-09

Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer

Phase 1/2 Terminated

12 enrolled 7 charts

GenitourinaryGynecologic

Prostatic Neoplasms, Endometrial Neoplasms

NCT01939028 2020-08-27

Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery

Phase NA Terminated

58 enrolled 12 charts

Endometrial Neoplasms

NCT03466034 2020-01-29

The Role of Hypoxia as a Selective Pressure for TP53 Mutations

Hypoxia, Adenocarcinoma, Mucinous, Endometrial Neoplasms

NCT02566811 2019-09-30

STATEC

Phase NA Terminated

Endometrial Neoplasms

NCT02907073 2019-05-17

Positron Emission Tomography (PET) Imaging Studies With NIS Reporter

Phase 1/2 Terminated

8 enrolled 4 charts

GynecologicPlasma cell

Endometrial Neoplasms, Neoplasms, Plasma Cell

NCT02900248 2019-04-02

N1

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckMyeloidOther hematologic neoplasmPlasma cellSarcomaThoracic

Anus Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Sarcoma, Skin Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Endometrial Neoplasms, Hematologic Neoplasms

NCT02589366 2018-10-15

Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium

Phase 1 Terminated

Endometrial Neoplasms

NCT02765698 2018-03-27

Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer

Endometrial Neoplasms

NCT00375804 2018-01-09

Racial Disparity in Endometrial Cancer

Endometrial Neoplasms

NCT01641497 2017-07-21

TOMOGYN

Phase NA Terminated

Endometrial Neoplasms

NCT01184053 2017-06-14

NRR

Phase 2 Terminated

3 enrolled 9 charts

Carcinoma, Neoplasm Metastasis, Recurrence, Endometrial Neoplasms

NCT00671606 2016-05-27

Hysteroscopic Lymphatic Mapping for Endometrial Cancer

Phase 2 Terminated

5 enrolled 2 charts

Endometrial Neoplasms

NCT01401829 2015-05-12

Psychosocial Benefits of Exercise in Endometrial Cancer Survivors

Phase 1 Terminated

Endometrial Neoplasms

NCT00936598 2014-04-24

Sleep and Endometrial Cancer

Phase NA Terminated

6 enrolled 5 charts

Pain, Endometrial Neoplasms

NCT00161226 2009-12-11

A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35

Endometrial Neoplasms